During the past decade, No.85 Hospital of PLA conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "No.85 Hospital of PLA" #1 sponsor was "Nanfang Hospital of Southern Medical University" with 5 trials, followed by "Xiamen Amoytop Biotech Co., Ltd." with 5 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Beijing Friendship Hospital" with 1 trials sponsored and "Drug Induced Liver Disease Study Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "No.85 Hospital of PLA" #1 collaborator was "Major Science and Technology Special Project of China Eleventh Five-year" with 3 trials as a collaborator, "Peking University First Hospital" with 3 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Beijing Trendful Kangjian Medical Information Consulting Limited Company" with 1 trials as a collaborator and "Beijing Union Pharmaceutical Factory" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "No.85 Hospital of PLA" are "Chronic Hepatitis B" (3 trials), "Hepatitis B, Chronic" (3 trials), "Chronic HBV Infections" (2 trials), "Chronic Hepatitis C" (2 trials) and "HBV" (2 trials). Many other conditions were trialed in "No.85 Hospital of PLA" in a lesser frequency.

Most popular intervention types in "No.85 Hospital of PLA" are "Drug" (14 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ypeginterferon alfa-2b" (4 trials), "Pegasys" (2 trials), "Peginterferon alfa-2a" (2 trials), "TAF" (2 trials) and "TAF Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "No.85 Hospital of PLA" are 16 trials for "All" genders.

Currently, there are NaN active trials in "No.85 Hospital of PLA". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in No.85 Hospital of PLA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in No.85 Hospital of PLA, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".